Clinical Trial Update: A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 trial evaluating the safety, effects and palatability of Sisunatovir in healthy adults, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Viruses | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19